Danielle Armas

460 total citations
18 papers, 312 citations indexed

About

Danielle Armas is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Danielle Armas has authored 18 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Danielle Armas's work include Cardiac electrophysiology and arrhythmias (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cardiomyopathy and Myosin Studies (2 papers). Danielle Armas is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cardiomyopathy and Myosin Studies (2 papers). Danielle Armas collaborates with scholars based in United States, Switzerland and Belgium. Danielle Armas's co-authors include Linh Thuy Nguyen, Richard D. Mamelok, Steven Lacy, Jaymes Holland, Dennis Swearingen, Scott D. Solomon, Caly Chien, James Jiao, Anna Osmukhina and Joan Carles and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and Clinical Pharmacokinetics.

In The Last Decade

Danielle Armas

17 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Armas United States 9 74 74 65 52 49 18 312
Shuang Zhou China 11 75 1.0× 32 0.4× 45 0.7× 43 0.8× 38 0.8× 30 316
Péter Barta Hungary 7 97 1.3× 58 0.8× 67 1.0× 35 0.7× 30 0.6× 9 519
Kunihisa Yamaguchi Japan 9 90 1.2× 100 1.4× 45 0.7× 43 0.8× 100 2.0× 55 349
İbrahim Halil Altıparmak Türkiye 11 58 0.8× 46 0.6× 129 2.0× 60 1.2× 70 1.4× 40 378
Javier Modrego Spain 13 140 1.9× 64 0.9× 141 2.2× 24 0.5× 66 1.3× 29 421
Michael Koziolek Germany 10 61 0.8× 42 0.6× 131 2.0× 158 3.0× 56 1.1× 33 538
Matthieu Sarabi France 12 63 0.9× 66 0.9× 70 1.1× 167 3.2× 65 1.3× 27 407
Langeza Saleh Netherlands 13 68 0.9× 52 0.7× 110 1.7× 29 0.6× 29 0.6× 33 624
Maria Wanic-Kossowska Poland 12 83 1.1× 51 0.7× 58 0.9× 15 0.3× 72 1.5× 47 452
Heather Yvonne Small United Kingdom 11 111 1.5× 35 0.5× 108 1.7× 42 0.8× 37 0.8× 22 465

Countries citing papers authored by Danielle Armas

Since Specialization
Citations

This map shows the geographic impact of Danielle Armas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Armas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Armas more than expected).

Fields of papers citing papers by Danielle Armas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Armas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Armas. The network helps show where Danielle Armas may publish in the future.

Co-authorship network of co-authors of Danielle Armas

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Armas. A scholar is included among the top collaborators of Danielle Armas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Armas. Danielle Armas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kulmatycki, Kenneth, Prasanna Kumar Nidamarthy, Elizabeth McNamara, et al.. (2025). Assessment of QT Interval Prolongation Using Concentration– QT Modeling for Iptacopan, an Oral Complement Factor B Inhibitor, in Healthy Individuals. Clinical and Translational Science. 18(10). e70361–e70361.
2.
Miao, Shichang, et al.. (2024). Food Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants. Clinical Pharmacology in Drug Development. 13(9). 1011–1023. 2 indexed citations
3.
Miao, Shichang, et al.. (2024). A phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants. Clinical and Translational Science. 17(7). e13878–e13878. 3 indexed citations
4.
Miao, Shichang, Pirow Bekker, Danielle Armas, et al.. (2024). Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants. Clinical Pharmacology in Drug Development. 13(5). 517–533. 7 indexed citations
5.
Malik, Fady I., Laura Robertson, Danielle Armas, et al.. (2022). A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants. JACC Basic to Translational Science. 7(8). 763–775. 31 indexed citations
6.
Rudd, Deanne Jackson, Kerry L. Fillgrove, Sabrina Fox‐Bosetti, et al.. (2021). Lack of a Clinically Meaningful Drug Interaction Between the HIV‐1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate. Clinical Pharmacology in Drug Development. 10(12). 1432–1441. 5 indexed citations
7.
Csonka, Dénes, Jaya Natarajan, Hans Stieltjes, et al.. (2021). Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic. Pharmacology Research & Perspectives. 9(5). e00846–e00846. 3 indexed citations
8.
Durán, Ignacio, Joan Carles, Iurie Bulat, et al.. (2020). Pharmacokinetic Drug–Drug Interaction of Apalutamide, Part 1: Clinical Studies in Healthy Men and Patients with Castration-Resistant Prostate Cancer. Clinical Pharmacokinetics. 59(9). 1135–1148. 42 indexed citations
9.
Xu, Jialin, et al.. (2020). Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants. The Journal of Clinical Pharmacology. 60(9). 1157–1165. 29 indexed citations
10.
Robertson, Laura, Danielle Armas, Anna Osmukhina, et al.. (2019). A First in Human Study of the Selective Cardiac Myosin Inhibitor, CK-3773274. Journal of Cardiac Failure. 25(8). S79–S80. 8 indexed citations
11.
Mammen, Mammen P., Danielle Armas, Andrew Hopkins, et al.. (2019). First-in-Human Phase 1 Study To Assess Safety, Tolerability, and Pharmacokinetics of a Novel Antifungal Drug, VL-2397, in Healthy Adults. Antimicrobial Agents and Chemotherapy. 63(11). 18 indexed citations
12.
Armas, Danielle, et al.. (2019). FRI-171-A phase 1 single ascending dose study of the safety, tolerability and pharmacokinetics of CRV431. Journal of Hepatology. 70(1). e464–e465. 3 indexed citations
13.
14.
Vajda, Eric G., Douglas Logan, Kenneth C. Lasseter, et al.. (2016). Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD‐6972 in healthy subjects and subjects with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 19(1). 24–32. 41 indexed citations
15.
Nguyen, Linh Thuy, Jaymes Holland, Richard D. Mamelok, et al.. (2015). Evaluation of the effect of food and gastric pH on the single‐dose pharmacokinetics of cabozantinib in healthy adult subjects. The Journal of Clinical Pharmacology. 55(11). 1293–1302. 63 indexed citations
16.
Armas, Danielle, et al.. (2015). A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation. Postgraduate Medicine. 127(6). 573–580. 20 indexed citations
17.
Marshall, William L., Wendy W. Yeh, Daria Stypinski, et al.. (2015). P0910 : No evidence of pharmacokinetic drug–drug interaction in healthy subjects between coadministered grazoprevir (MK-5172)/elbasvir (MK-8742) and sofosbuvir. Journal of Hepatology. 62. S686–S686. 3 indexed citations
18.
Grover, Michael, et al.. (2011). Identifying Patients at Risk for Obstructive Sleep Apnea in a Primary Care Practice. The Journal of the American Board of Family Medicine. 24(2). 152–160. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuang Zhou Breakdown of academic impact, for papers by Péter Barta Breakdown of academic impact, for papers by Kunihisa Yamaguchi Breakdown of academic impact, for papers by İbrahim Halil Altıparmak Breakdown of academic impact, for papers by Javier Modrego Breakdown of academic impact, for papers by Michael Koziolek Breakdown of academic impact, for papers by Matthieu Sarabi Breakdown of academic impact, for papers by Langeza Saleh Breakdown of academic impact, for papers by Maria Wanic-Kossowska Breakdown of academic impact, for papers by Heather Yvonne Small
Rankless by CCL
2026